AstraZeneca thinks shot can stop severe disease from South Africa COVID variant

AstraZeneca confirmed that early data from a small trial, first reported by the Financial Times, had shown limited efficacy for the vaccine against mild disease primarily due to this variant.

from world 1 https://ift.tt/2YVcqOo